Search

Your search keyword '"Foca, F."' showing total 203 results

Search Constraints

Start Over You searched for: Author "Foca, F." Remove constraint Author: "Foca, F."
203 results on '"Foca, F."'

Search Results

2. Therapy with 177Lu-PSMA-617 in advanced mCRPC patients: Results of the phase 2 prospective trial IRST-185.03 (EUDRACT: 2016-002732-32)

3. Malignant Pleural Mesothelioma and Radiotherapy: Lung Toxicity Results of an Interim Analysis in Prospective Pilot Trial

4. Hyperbaric Oxygen Therapy plus Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma

6. Radiotherapy and palliative care outpatient clinic: a new healthcare integrated model in Italy

7. 84P Autologous ECM-composed scaffolds and zebrafish PDXs for individualized theranostics in rare neuroendocrine neoplasms

8. 48P Phase II trial on vaccination with autologous dendritic cells loaded with autologous tumour homogenate in resected glioblastoma (COMBI-GVAX): Clinical results of the first step

9. P992: OUTCOMES OF GLOBAL COAGULATION ASSAYS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS WITH RESPECT TO THEIR CLINICAL AND GENETIC DETERMINANTS OF CLONAL EVOLUTION

11. 381TiP Vaccination with autologous dendritic cells loaded with autologous tumour homogenate in resected glioblastoma: A phase II study (CombiGVax)

12. 1296P Immune checkpoint inhibitors with or without bone targeted therapy in NSCLC patients with bone metastases and prognostic significance of neutrophil-to-lymphocyte ratio

13. 1103P 177Lu-DOTATATE efficacy and safety in functioning neuroendocrine tumors: A joint analysis of phase II prospective clinical trials

17. GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients

19. 1175P Temozolomide alone or combined with capecitabine for the treatment of metastatic neuroendocrine neoplasia: A “Real World” data analysis

20. 1170P The prognostic role of DLL3 expression in high-grade gastroenteropancreatic neuroendocrine neoplasms

21. 606P Novel miRNA-based assay for GEP-NENs management

24. miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer

25. First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma

26. OUTCOMES THAT MATTER TO PATIENTS? THE GERIATRIC ONCOLOGY SURGICAL ASSESSMENT AND FUNCTIONAL RECOVERY AFTER SURGERY (GOSAFE) STUDY: SUBGROUP ANALYSIS OF 440 PATIENTS UNDERGOING COLORECTAL CANCER SURGERY

27. PATIENT-REPORTED OUTCOMES MEASURES (PROMS) IN GERIATRIC PATIENTS UNDERGOING MAJOR SURGERY FOR SOLID CANCER: 90-DAY PRELIMINARY REPORT ON 643 PATIENTS FROM THE GERIATRIC ONCOLOGY SURGICAL ASSESSMENT AND FUNCTIONAL RECOVERY AFTER SURGERY (GOSAFE) STUDY

29. EP1.16-04 Real World Clinical Outcomes for Metastatic Non-Small Cell Lung Cancer (mNSCLC) at IRST Italy

32. CAPTEM or FOLFIRI as second-line therapy in neuroendocrine carcinomas and exploratory analysis of predictive role of PET imaging and biological markers (SENECA study)

33. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy

34. The advantage of women in cancer survival: An analysis of EUROCARE-4 data

35. Bone health management in early breast cancer patients: an Italian Osteoncology Center experience

36. Metastatic neuroendocrine neoplasia (mNEN) treatments in over 70 years (y) old patients: A retrospective outcome analysis

37. Ageing and other factors behind recent cancer incidence and mortality trends in Italy

38. KO1 - PATIENT-REPORTED OUTCOMES MEASURES (PROMS) IN GERIATRIC PATIENTS UNDERGOING MAJOR SURGERY FOR SOLID CANCER: 90-DAY PRELIMINARY REPORT ON 643 PATIENTS FROM THE GERIATRIC ONCOLOGY SURGICAL ASSESSMENT AND FUNCTIONAL RECOVERY AFTER SURGERY (GOSAFE) STUDY

39. O01 - OUTCOMES THAT MATTER TO PATIENTS? THE GERIATRIC ONCOLOGY SURGICAL ASSESSMENT AND FUNCTIONAL RECOVERY AFTER SURGERY (GOSAFE) STUDY: SUBGROUP ANALYSIS OF 440 PATIENTS UNDERGOING COLORECTAL CANCER SURGERY

41. Phase II randomised clinical study of metformin plus chemotherapy vs chemotherapy alone in HER2 negative metastatic breast cancer: final results of the MYME trial

42. Retrospective analysis of the efficacy of somatostatin analogs (SSA) in metastatic pulmonary neuroendocrine tumors and prognostic significance of FDG-PET

43. Recombinant granulocyte colony-stimulating factors (rG-CSFs) in the management of NEUtropenia induced by anthracyclines and ifosfamide in patients with soft tissue SARcomas (NEUSAR)

45. I TUMORI IN ITALIA - RAPPORTO 2013: Tumori multipli = ITALIAN CANCER FIGURES - REPORT 2013: Multiple tumours

46. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy

47. Predictions of survival up to 10 years after diagnosis for european women with breast cancer in 2000-2002

48. Invasive extramammary Paget's disease and the risk for secondary tumours in Europe

49. Oesophageal cancer survival in Europe: A EUROCARE-4 study

50. Survival of European patients with central nervous system tumors

Catalog

Books, media, physical & digital resources